Subscribe To
Willow biosciences shares take off on biopharma manufacturing collaboration announcement
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF)' Canadian-listed shares had added more than 23% in the early afternoon on Monday after it announced th...
August 21, 2023, 12:58 pm
Cramer dubs regeneron stock a ‘favourite' after two new fda approvals
Regeneron pharmaceuticals Inc (NASDAQ: REGN) secured FDA approval for Eylea HD – a higher-dose of its...
August 21, 2023, 12:45 pm
Phio pharmaceuticals announces dosing of first patient in collaborative clinical trial with agonox, inc. and providence cancer institute
Trial targeting treatment of metastatic melanoma and other solid tumors MARLBOROUGH, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) — Phio ...
August 21, 2023, 11:30 am
5 large drug stocks to watch as new drug approvals & m&a gain pace
Drug, biotech companies are likely to see significant innovation. In the Large-Cap pharmaceuticals indu...
August 21, 2023, 11:16 am
Tonix pharmaceuticals announces results of pre-ind meeting with fda for tnx-801 as a potential vaccine to prevent mpox and smallpox
Phase 1/2 Clinical Trial of TNX-801 for the Prevention of Mpox and Smallpox to Commence Following Submission of an IND TNX-801 is Based on a Proprieta...
August 21, 2023, 11:00 am
Why is timber pharmaceuticals (tmbr) stock up 96% today?
Timber pharmaceuticals (NYSEMKT: TMBR ) stock is undergoing a massive rally on Monday after announcing ...
August 21, 2023, 10:58 am
Regeneron's eylea could return to growth after nod to high-dose version- analysts
A quicker-than-expected U.S. approval for Regeneron pharmaceuticals' high-dose eye disease drug, Eylea,...
August 21, 2023, 9:42 am
Regeneron pharmaceuticals shares rise on fda approval of higher dose of eye disorder drug eylea
Regeneron pharmaceuticals (NASDAQ:REGN) shares moved higher in pre-market trading after the biotechnolo...
August 21, 2023, 9:01 am
Eyepoint: well-funded and catalyst-rich, but not without risks
EyePoint pharmaceuticals is developing the EYP-1901 treatment for wet age-related macular degeneration ...
August 21, 2023, 8:31 am
Willow biosciences announces collaboration with nasdaq-listed biopharma
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) has announced a collaboration with an unnamed Nasdaq-listed biopharma company to develop new sustainab...
August 21, 2023, 8:27 am
Why is china sxt pharmaceuticals (sxtc) stock up 110% today?
China SXT pharmaceuticals (NASDAQ: SXTC ) stock is rocketing higher on Monday despite a lack of news f...
August 21, 2023, 7:53 am
Regeneron shares climb after fda approval of macular degeneration treatment
Shares of Regeneron pharmaceuticals Inc. REGN, +1.97% gained 1.4% premarket on Monday after the company...
August 21, 2023, 7:52 am
Should you invest in the spdr s&p pharmaceuticals etf (xph)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P pharm...
August 21, 2023, 7:31 am
Is regeneron pharmaceuticals still a top growth stock?
Regeneron pharmaceuticals has delivered market-beating results for shareholders over the prior 10 years...
August 21, 2023, 6:30 am
Ihe: a highly concentrated portfolio is able to generate growth over the long run
iShares U.S. pharmaceuticals ETF invests almost 80 percent of its assets in its top 10 holdings, and 48...
August 21, 2023, 6:18 am
The 3 most undervalued pharma stocks to buy now: august 2023
There are sectors in the economy that go through an extended period of trending sideways to lower. A good example is the ...
August 21, 2023, 5:30 am
Chinese property firm country garden set to be removed from hong kong’s hang seng index
Chinese real estate company Country Garden Holdings is set to be removed from Hong Kong’s Hang Seng Index.Shares of the firm are down around 70% sin...
August 21, 2023, 2:25 am
Shareholder investigation: halper sadeh llc investigates reta, ael, prds, cell
NEW YORK, Aug. 20, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...
August 20, 2023, 7:40 pm
Rosen, recognized investor counsel, encourages apellis pharmaceuticals, inc. investors with losses to secure counsel before important deadline in securities class action – apls
NEW YORK, Aug. 20, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis
August 20, 2023, 4:10 pm
Madrigal's resmetirom nears commercialization despite market concerns
Madrigal pharmaceuticals is developing resmetirom, a drug for non-alcoholic steatohepatitis and fatty l...
August 20, 2023, 10:27 am